Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Sheldon

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Antimicrobial Agents and Chemotherapy|April 13, 2016
Barrier-Independent, Fitness-Associated Differences in Sofosbuvir Efficacy against Hepatitis C VirusIsabel Gallego, Julie Sheldon, Elena Moreno, et al.
Journal of Virology|May 3, 2013
Response of hepatitis C virus to long-term passage in the presence of alpha interferon: multiple mutations and a common phenotypeCelia Perales, Nathan M Beach, Isabel Gallego, et al.
Plos One|August 27, 2013
Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesisAna M Ortega-Prieto, Julie Sheldon, Ana Grande-Pérez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 17, 2007
Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B virus-coinfected patientsBelén Ramos, Marina Núñez, Luz Martín-Carbonero, et al.
Expert Opinion on Emerging Drugs|March 7, 2008
Emerging drugs for hepatitis CVincent Soriano, Antonio Madejon, Eugenia Vispo, et al.
Microbiology Spectrum|June 21, 2023
Mouse Liver-Expressed Shiftless Is an Evolutionarily Conserved Antiviral Effector Restricting Human and Murine HepacivirusesYudi Zhang, Volker Kinast, Julie Sheldon, et al.
Plos Pathogens|November 15, 2023
The matrix metalloproteinase ADAM10 supports hepatitis C virus entry and cell-to-cell spread via its sheddase activityBelén Carriquí-Madroñal, Julie Sheldon, Mara Duven, et al.
Antiviral Therapy|October 13, 2005
Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovirJulie Sheldon, Nuria Camino, Berta Rodés, et al.
Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians|January 14, 2023
RABIES DIAGNOSIS AND RESPONSE TO VACCINATION IN SOUTHERN TAMANDUA (<i>TAMANDUA TETRADACTYLA</i>)Andrew C Cushing, Julie Sheldon, Laura Martinelli, et al.
Journal of Hepatology|March 4, 2015
Hepatitis C virus-mediated Aurora B kinase inhibition modulates inflammatory pathway and viral infectivityAntonio Madejón, Julie Sheldon, Irene Francisco-Recuero, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|April 13, 2016
Barrier-Independent, Fitness-Associated Differences in Sofosbuvir Efficacy against Hepatitis C VirusIsabel Gallego, Julie Sheldon, Elena Moreno, et al.
Journal of Virology|May 3, 2013
Response of hepatitis C virus to long-term passage in the presence of alpha interferon: multiple mutations and a common phenotypeCelia Perales, Nathan M Beach, Isabel Gallego, et al.
Plos One|August 27, 2013
Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesisAna M Ortega-Prieto, Julie Sheldon, Ana Grande-Pérez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 17, 2007
Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B virus-coinfected patientsBelén Ramos, Marina Núñez, Luz Martín-Carbonero, et al.
Expert Opinion on Emerging Drugs|March 7, 2008
Emerging drugs for hepatitis CVincent Soriano, Antonio Madejon, Eugenia Vispo, et al.
Microbiology Spectrum|June 21, 2023
Mouse Liver-Expressed Shiftless Is an Evolutionarily Conserved Antiviral Effector Restricting Human and Murine HepacivirusesYudi Zhang, Volker Kinast, Julie Sheldon, et al.
Plos Pathogens|November 15, 2023
The matrix metalloproteinase ADAM10 supports hepatitis C virus entry and cell-to-cell spread via its sheddase activityBelén Carriquí-Madroñal, Julie Sheldon, Mara Duven, et al.
Antiviral Therapy|October 13, 2005
Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovirJulie Sheldon, Nuria Camino, Berta Rodés, et al.
Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians|January 14, 2023
RABIES DIAGNOSIS AND RESPONSE TO VACCINATION IN SOUTHERN TAMANDUA (<i>TAMANDUA TETRADACTYLA</i>)Andrew C Cushing, Julie Sheldon, Laura Martinelli, et al.
Journal of Hepatology|March 4, 2015
Hepatitis C virus-mediated Aurora B kinase inhibition modulates inflammatory pathway and viral infectivityAntonio Madejón, Julie Sheldon, Irene Francisco-Recuero, et al.
Pageof 6